- Export of cannabis – Canadian businesses exported more dried medical cannabis than ever last year, but that growth is expected to be challenged when the country’s main export destination – Germany – initiates local production later this year. In 2019, federally regulated producers in Canada exported roughly 3,740 kilograms (8,245 pounds) of dried cannabis for medical and scientific use, according to data Health Canada provided to Marijuana Business Daily. That’s 160% more than Canada’s 2018 exports, which amounted to 1,460 kilograms. Reference material sourced here
- The future in psychedelics – Unlike medical cannabis, which is still navigating a litany of federal research restrictions, psychedelic substances, including ketamine, psilocybin and ibogaine, have been granted FDA approval for clinical trials. In fact, in 2018 and 2019, the FDA designated psilocybin, the psychoactive compound found in mushrooms, as a “Breakthrough Therapy” to treat clinical depression. This coveted classification allows the developers of the drug to conduct clinical trials with more regulatory support and fast-tracks the development and review of final treatments. A wonderful piece of content sources from Forbes
Highlights of the Week:
- Powerful psychedelic drug ibogaine could help people kick opioid addictions
- Why the future of mental health care may lie in psychedelics
- Israel government announces plan to advance cannabis legalisation reforms
- William Shatner says he uses ‘magical’ cannabinoids to treat aches and pains
- A 500-day journey prescribing medicinal cannabis in Australia
- Lifespot Health grants license agreement to Jayex Healthcare
- Cannasouth eyes move into animal products to take the edge off
About Adam Isaac Miller:
Adam spent over 8 years building various B2B businesses within education, investment, and medicinal cannabis, with progressive roles including business development, strategy, product development and project management. He has consulted private and listed cannabis producers and ancillary businesses since 2015, as one of the early entrants and experts in the burgeoning Australian cannabis industry. Adam founded and currently sits on the board of The Medical Cannabis Council, Australia’s largest not-for-profit industry body. He is a frequent public speaker and publishes a widely read industry newsletter. Adam earned a Bachelor of Entrepreneurship from the Royal Melbourne Institute of Technology.
Adam has appeared in several major news outlets including the Sydney Morning Herald, The Australian Financial Review, Startup Smart, SBS, SkyNews, MJBizDaily, and other major publications.